NIH-funded research R01 grant

Improving prostate cancer care with advanced imaging techniques

Official title: Optimizing prostate cancer care: integrating risks, benefits, and patient experiences in the new era of molecular imaging

Funded at Yale University · NIH-10928716 · Data updated 2026-11-12

This study is looking at how new PET scans can help find prostate cancer earlier and improve treatment, while also checking for any possible downsides like side effects or stress, so that patients and doctors can make better choices together.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startSeptember 13, 2023
Project endAugust 31, 2028
Funding year2024
Award (this year)$628,694
NIH project number5R01CA281959-02
Project IDNIH-10928716 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include men diagnosed with prostate cancer who are considering or have undergone PET imaging as part of their treatment.

Less likely to help

Patients who are not diagnosed with prostate cancer or those who are not candidates for PET imaging may not benefit from this research.

What this research studies

This research investigates the impact of new positron-emission tomography (PET) scans on prostate cancer diagnosis and treatment. It aims to understand how these imaging techniques can improve patient outcomes by detecting cancer earlier, while also considering potential negative effects such as increased treatment side effects and psychological stress. By analyzing data from various sources, the research will develop a decision model to help patients and healthcare providers weigh the benefits and risks of PET imaging in their treatment plans.

Why it matters

Potential benefit: If successful, this research could lead to more informed decision-making for prostate cancer patients, ultimately improving their treatment outcomes and quality of life.

How similar studies have gone: Other research has shown promising results with advanced imaging techniques in cancer care, suggesting that this approach could lead to significant improvements in patient outcomes.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: Leapman, Michael Stuart — Yale University
  • Study coordinator: Leapman, Michael Stuart

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.